Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial
NCT01047800 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2017-04-26
Summary
Background:
Functional gastrointestinal disorder (FGID) is the most common gastrointestinal disease in daily clinical practice. The disease is symptomatic but has no identifiable cause by standard diagnostic tests such as endoscopy. It is characterized by its frequent relapses and thus the disease causes a significant level of stress and anxiety to patients. Due to the complexity and chronicity of the disease, it is believed that appropriate counseling on the nature and management of the disease is necessary to decrease patient's anxiety level and improve quality of life.
Indication:
Patients who have symptoms suggestive of FGID including non-erosive gastroesophageal reflux disease (NERD), functional dyspepsia (FD) or irritable bowel syndrome (IBS).
Aim:
To validate the effectiveness of counseling in patients suffering from FGID.
Method:
Patients recruited to the study will follow the usual management of patients attending the Gastroenterology specialty clinic in Prince of Wales Hospital. Standard blood tests and endoscopy will be performed. Standard medication will be given to the patients for 8 weeks after endoscopy and the patients will come back to the specialty clinic for a final visit.
The patient will be given an "on-demand follow up within 1 year" option at final visit. The patient will decide if he/she wants to come back to our specialty clinic to follow up his/her problem within one year.
Follow-up after Final Visit Follow-up questionnaires will be mailed to patients 6 months, 1 and 2 years after Final visit.
Randomization:
All the patients will be randomized into two groups in First Visit: 1) Control group, and 2) Counseling group. Both groups of patients will follow the above protocol, except that 2 extra counseling sessions will be arranged for the Counseling group immediately after visiting the physician.
Conditions
- Non-erosive Gastroesophageal Reflux Disease
- Functional Dyspepsia
- Irritable Bowel Syndrome
Interventions
- BEHAVIORAL
-
Counseling
Two extra counseling sessions will be arranged for the Counseling group immediately after visiting the physician in First and Final visits. Each session lasts for about 15 minutes with the following content: First visit: prevalence of FGID in Hong Kong, chronicity nature of the disease, negative endoscopy result to be expected, time to answer patient's questions Final visit : prevalence of FGID in Hong Kong (reinforcement), chronicity nature of the disease (reinforcement), explanation of the endoscopy result, management of disease via lifestyle modification, use of medication, need for further or repeated investigation, time to answer patient's questions.
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Justin C.Y. Wu, MBChB(CUHK) · Chinese University of Hong Kong
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2015-05-31
- Completion
- 2016-12-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Prevalence and Associated Factors of Functional Gastrointestinal Disorders Among Children
NCT05605405 ·Status: UNKNOWN
-
Evaluation of Patients With Gastrointestinal Disease
NCT05041374 ·Status: RECRUITING
-
NLP to Aid in the Evaluation and Diagnosis of FGIDs
NCT05501028 ·Status: ENROLLING_BY_INVITATION
-
Mucosal Barrier Defects in Functional Dyspepsia by Confocal Laser Endomicroscopy
NCT01006642 ·Status: UNKNOWN
-
The Effect of Multiple Medications on the Incidence of Organic Dyspepsia
NCT05524675 ·Status: UNKNOWN
-
Evaluation of People With Gastrointestinal Disease
NCT01639924 ·Status: COMPLETED
-
Assessment of GI Function to a Large Test Meal by Non-invasive Imaging
NCT03007433 ·Status: COMPLETED ·Phase: NA
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA
-
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
NCT04647955 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT06931223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients
NCT03844100 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Functional Dyspepsia Hypnosis
NCT03884270 ·Status: COMPLETED ·Phase: NA
-
Effect of Gastrogenic Microbiota in FD
NCT06760897 ·Status: COMPLETED ·Phase: NA
-
Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
NCT05718960 ·Status: RECRUITING ·Phase: NA
-
Influence of Bile Acids on Bacterial Uptake in Functional Dyspepsia
NCT03296267 ·Status: COMPLETED ·Phase: NA
-
The Impact of COVID-19 Infection on the Symptoms of Functional Dyspepsia
NCT05749692 ·Status: UNKNOWN
-
Indiana University Gastrointestinal Motility Diagnosis Registry
NCT04506593 ·Status: RECRUITING
-
Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen
NCT04454996 ·Status: UNKNOWN ·Phase: PHASE4
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
NCT06756139 ·Status: RECRUITING ·Phase: NA
-
Effect of Genetic Association With Functional Dyspepsia and Mood Disorders
NCT02282995 ·Status: UNKNOWN
-
Duodenal Microbiota in Functional Dyspepsia
NCT06326918 ·Status: RECRUITING
-
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
NCT05655819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia
NCT05823636 ·Status: RECRUITING
-
Assessment of Gastric Motility on Funtional Dyspepsia and Joint Hypermobility Syndrome
NCT04279990 ·Status: COMPLETED